Cancer Vaccines

Cancer vaccines focus on both therapeutic and preventive approaches to stimulate the immune system against tumor cells. These vaccines target specific tumor-associated antigens to enhance immune recognition and destruction of cancer cells. Research in this track includes peptide-based vaccines, dendritic cell vaccines, and nucleic acid–based platforms designed to induce strong, durable anti-tumor responses. Emphasis is placed on improving vaccine efficacy, personalizing treatments, and combining vaccines with other immunotherapies such as checkpoint inhibitors. Advances in understanding tumor immunology and immune evasion mechanisms are driving the development of safer, more effective cancer vaccines that aim to prevent tumor growth and improve patient outcomes.

    Related Conference of Cancer Vaccines

    November 16-17, 2026

    11th Global Summit on Midwifery and Womens Health

    Tokyo, Japan
    December 16-17, 2026

    7th Global Summit on Public Health

    Amsterdam, Netherlands
    January 18-19, 2027

    44th International Conference on Womens Health

    Bangkok, Thailand
    January 18-19, 2027

    10th World Congress on PCOS and Reproductive Healthcare

    Bangkok, Thailand
    February 01-02, 2027

    9th International Conference on Digital Health

    London, UK
    February 15-16, 2027

    23rd World Congress on Healthcare & Technologies

    Paris, France
    May 17-18, 2027

    38th European Heart and Heart Failure Congress

    Paris, France
    July 26-27, 2027

    5th Global Conference on Aging and Gerontology

    Paris, France
    August 24-25, 2027

    23rd Global Biomarkers and Clinical Research Summit

    Paris, France

    Cancer Vaccines Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in